JXFGF Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (11 apr 2024 @ 15:34):

Stats
Dagens volum	1 323.00
Gjennomsnittsvolum	353.00
Markedsverdi	538.77M
EPS	$0 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	10.00
ATR14	$0.00100 (0.50%)

Volum Korrelasjon

Lang: -0.38 (neutral)

Kort: -0.59 (weak negative)

Signal:(0.055) Neutral

Jinxin Fertility Group Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Jinxin Fertility Group Korrelasjon - Valuta/Råvare

-0.12
( neutral )

-0.51
( weak negative )

0.00
( neutral )

-0.75
( moderate negative )

0.00
( neutral )

0.71
( moderate )

Jinxin Fertility Group Økonomi

Annual	2023
Omsetning:	$2.79B
Bruttogevinst:	$1.18B (42.15 %)
EPS:	$0.130

FY	2023
Omsetning:	$2.79B
Bruttogevinst:	$1.18B (42.15 %)
EPS:	$0.130

FY	2022
Omsetning:	$2.36B
Bruttogevinst:	$874.32M (36.98 %)
EPS:	$0.0485

Financial Reports:

No articles found.

Jinxin Fertility Group Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.